Abstract 2068P
Background
Sexual dysfunction is a frequently seen late effect in patients treated for testicular germ cell tumour (TGCT). Therefore, monitoring of sexual dysfunction is essential. The Utrecht Symptom Diary (USD) helps monitoring cancer symptoms, but items regarding sexuality are missing. Adding these symptoms may provide a better tailored tool, enhance monitoring of late effects on sexuality, and might help to address this topic. Therefore, the aim of this study was to explore perspectives and concerns on late effects regarding sexuality among adolescents and young adults (AYAs) being treated for TGCT to adapt the USD to make it suitable for follow-up care for these patients.
Methods
Individual, semi-structured interviews were conducted with thirteen AYAs from one centre of expertise for TGCT in the Netherlands. Patients were purposively sampled and using maximum variation. Data was analysed using Braun and Clark’s thematic analysis.
Results
Interviews revealed seven overarching themes which interact and overlap: fulfilment to have children, rediscover sexuality, insecurity about sexual performance, acceptance of physical change, loss of masculinity, burden on relationship, and need to talk about sexuality. Concerns related to the fulfilment to have children seems to play a major role.
Conclusions
Results help to better understand these men’s thoughts and experiences related to late effects regarding sexuality and gives healthcare professionals the opportunity to act on these topics by discussing it in the consulting room. Partner involvement seems beneficial.
Clinical trial identification
Editorial acknowledgement
Legal entity responsible for the study
The author.
Funding
Has not received any funding.
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
2086P - Management of opioids use disorder in cancer survivors
Presenter: Khalida Berkane
Session: Poster session 06
2087P - Impact of cancer pain on quality of life and financial well-being: A cross-sectional study on symptom management
Presenter: Raffaele Giusti
Session: Poster session 06
2088P - Management of cancer treatment-induced bone loss in patients with breast and hormone sensitive prostate cancer: AIOM survey among Italian oncologists
Presenter: Anna Amela Valsecchi
Session: Poster session 06
2090P - Management of trastuzumab deruxtecan-related nausea and vomiting in real-world practice
Presenter: Luca Licata
Session: Poster session 06
2091P - Dermocosmetics in management of cancer-related skin toxicities: International expert consensus highlighting the key role of oncology nurses
Presenter: Pascale Dielenseger
Session: Poster session 06
2092P - Bone loss in premenopausal Algerian women treated with chemotherapy for early-stage of breast cancer: Evaluation by DXA and identification of associated risk factors
Presenter: MACHEROUM Fatma zohra
Session: Poster session 06
2093P - Bioelectrical Impedance phase angle and obesity as a prognostic indicator in metastatic gastric cancer patients receiving second-line chemotherapy
Presenter: SangUk Han
Session: Poster session 06
2094P - A multicenter phase II trial of the triplet antiemetic therapy with palonosetron, aprepitant and olanzapine for highly emetogenic chemotherapy in breast cancer
Presenter: Shinya Takada
Session: Poster session 06
2095P - Cancer rehabilitation program for cancer-related fatigue
Presenter: Aizhan Bekisheva
Session: Poster session 06